Natural Polyphenolic Nanodots for Alzheimer's Disease Treatment
- 6 December 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (3) , e2308393
Abstract
The abnormal amyloid‐β accumulation is essential and obbligato in Alzheimer's disease pathogenesis and natural polyphenols exhibit great potential as amyloid aggregation inhibitors. However, the poor metabolic stability, low bioavailability, and weak blood–brain barrier crossing ability of natural polyphenol molecules fail to meet clinical needs. Here, a universal protocol to prepare natural polyphenolic nanodots is developed by heating in aqueous solution without unacceptable additives. The nanodots are able to not only inhibit amyloid‐β fibrillization and trigger the fibril disaggregation, but mitigate the amyloid‐β‐plaque‐induced cascade impairments including normalizing oxidative microenvironment, altering microglial polarization, and rescuing neuronal death and synaptic loss, which results in significant improvements in recognition and cognition deficits in transgenic mice. More importantly, natural polyphenolic nanodots possess stronger antiamyloidogenic performance compared with small molecule, as well as penetrate the blood–brain barrier. The excellent biocompatibility further guarantees the potential of natural polyphenolic nanodots for clinical applications. It is expected that natural polyphenolic nanodots provide an attractive paradigm to support the development of the therapeutics for Alzheimer's disease.Keywords
Funding Information
- National Natural Science Foundation of China (52173132)
This publication has 58 references indexed in Scilit:
- The road to restoring neural circuits for the treatment of Alzheimer's diseaseNature, 2016
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer diseaseAnnals of Neurology, 2014
- Colorless Multifunctional Coatings Inspired by Polyphenols Found in Tea, Chocolate, and WineAngewandte Chemie International Edition, 2013
- Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaProceedings of the National Academy of Sciences, 2013
- Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid FibrilsJournal of the American Chemical Society, 2013
- The Nogo Receptor Family Restricts Synapse Number in the Developing HippocampusNeuron, 2012
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- Oxidative polymerization of phenols revisitedProgress in Polymer Science, 2003
- Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's diseaseNature, 1995
- Deuterium effects on singlet oxygen lifetimes in solutions. New test of singlet oxygen reactionsJournal of the American Chemical Society, 1972